On 30 May 2016
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2016 To take on record the audited results for the quarter / financial year ended on 31 March, 2016 & To recommend Dividend, if any.Powered by Capital Market - Live News